Kate Hudson shared a snap of a sweet moment with her 7-year-old daughter Rani on Instagram. She also shared a few photos of her latest press tour look, a monochromatic brown leather outfit. Hudson ...

Rani Therapeutics Holdings, Inc. targets a new potential oral delivery of biologic drugs via the RaniPill. This could eventually replace injections and improve patient adherence. Their pipeline has RT ...

After several years in development, Warner Bros. Pictures Animation and New Line Cinema are finally moving ahead with the “Hello Kitty” feature film, dating it for July 21, 2028. “Hello Hollywood ...

Kate Hudson's seven-year-old daughter Rani Rose got her ears pierced. The Running Point actress proudly filmed the milestone and later posted the video on TikTok. Hudson shares Rani with her longtime ...

South Cone Investments Limited Partnership, a ten percent owner of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), sold 5,923,000 shares of Class A Common Stock on October 20 and 21, 2025, for a total ...

Rani Therapeutics is initiated at a Buy rating, driven by major pipeline advancements and strong partnership momentum. RANI secured a $1.085 billion collaboration with Chugai Pharmaceutical, ...

With investors perched on the edge of their seats for months, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announces a deal including upfront milestones and partner-funded asset development. On ...

Rani Therapeutics Holdings recently announced a collaboration and license agreement with Chugai Pharmaceutical for the joint development and commercialization of an oral product combining Rani’s ...

Oct 17 (Reuters) - Rani Therapeutics (RANI.O), opens new tab on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's (4519.T), opens new tab experimental ...

Shares of Rani Therapeutics Holdings have doubled, to $1.12, in premarket trading after the company said it has entered into a collaboration and license agreement with Chugai Pharmaceutical. The ...

The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...

The collaboration aims to develop an oral product combining Rani’s RaniPill technology with Chugai’s rare disease antibody. Notably, Chugai has options to extend rights to up to five additional drug ...